Abstract
Autologous hematopoietic SCT (auto-SCT) has been effective therapy for refractory disease, in both malignancies and severe autoimmune diseases. It seems feasible and safe for refractory celiac disease (RCD) type II, although long-term results have not been evaluated yet. With current therapies, progression into enteropathy-associated T-cell lymphoma (EATL) occurs in 60–80% patients, with a high mortality rate. Therefore, it is important to evaluate new treatment strategies. Between March 2004 and February 2010, 18 RCD II patients were evaluated for auto-SCT preceded by conditioning with fludarabine and melphalan, as a consequence of unresponsiveness to cladribine therapy. Adverse events, survival rate, EATL development and change in clinical, histological and immunological course were monitored. Thirteen patients were transplanted successfully and followed up for >2 years, 4-year survival rate was 66%. Only one patient died because of transplant-related complications. The majority of patients showed an impressive clinical improvement and five a complete histological remission. In five patients, auto-SCT could not be performed; they all died with a median survival of 5.5 months. EATL was observed in one transplanted patient, only after 4 years of follow-up. Auto-SCT after conditioning with high-dose chemotherapy in RCD II patients unresponsive to cladribine therapy is feasible and seems promising.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005; 128 (4 Suppl 1): S57–S67.
Sollid LM . Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53–81.
Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003; 100: 12390–12395.
Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000; 356: 203–208.
Daum S, Cellier C, Mulder CJ . Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19: 413–424.
Daum S, Hummel M, Weiss D, Peters M, Wiedenmann B, Schaper F et al. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma. Digestion 2000; 62: 60–65.
Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol 2008; 126: 48–56.
Verbeek WH, Schreurs MW, Visser OJ, von Blomberg BM, Al-Toma A, Mulder CJ . Novel approaches in the management of refractory coeliac disease. Expert Rev Clin Immunol 2008; 4: 205–219.
Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ . Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007; 56: 1373–1378.
Bishton MJ, Haynes AP . Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma. Br J Haematol 2007; 136: 111–113.
Goerres MS, Meijer JW, Wahab PJ, Kerckhaert JA, Groenen PJ, Van Krieken JH et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18: 487–494.
van Bekkum DW . Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 2004; 17: 201–222.
Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van LJ et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 year's experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010; 95: 284–292.
Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643–645.
Verburg RJ, Toes RE, Fibbe WE, Breedveld FC, van Laar JM . High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol 2002; 63: 627–637.
Al-Toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007; 109: 2243–2249.
Biagi F, Corazza GR . Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 2001; 13: 561–565.
Mallant M, Hadithi M, Al-Toma AB, Kater M, Jacobs M, Manoliu R et al. Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J Gastroenterol 2007; 13: 1696–1700.
Hadithi M, Mallant M, Oudejans J, van Waesberghe JH, Mulder CJ, Comans EF . 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006; 47: 1622–1627.
Van Weyenberg SJ, van Waesberghe JH, Ell C, Pohl J . Enteroscopy and its relationship to radiological small bowel imaging. Gastrointest Endosc Clin N Am 2009; 19: 389–407.
Rondonotti E, Villa F, Mulder CJ, Jacobs MA, de FR . Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol 2007; 13: 6140–6149.
Hadithi M, Al-Toma A, Oudejans J, van Bodegraven AA, Mulder CJ, Jacobs M . The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol 2007; 102: 987–996.
Isaacson PG, Chott A, Ott G, Stein H . Enteropathy-associated T-cell lymphoma. In: Swedlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research on Cancer: Lyon, 2008, p. 289–291.
Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene phosphoamide. J Chronic Dis 2009; 11: 7–33 1960. Ref type: Journal (full).
Verbeek WH, von Blomberg BM, Scholten PE, Kuik DJ, Mulder CJ, Schreurs MW . The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol 2008; 103: 3152–3158.
Cellier C, Patey N, Mauvieux L, Jabri B, Delabesse E, Cervoni JP et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471–481.
Rostami K, Mulder CJ, Werre JM, van Beukelen FR, Kerchhaert J, Crusius JB et al. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 1999; 34: 276–279.
Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009; 136: 81–90.
Rubio-Tapia A, Kelly DG, Lahr BD, Dogan A, Wu TT, Murray JA . Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009; 136: 99–107.
Maurino E, Niveloni S, Chernavsky A, Pedreira S, Mazure R, Vazquez H et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002; 97: 2595–2602.
Tack GJ, Verbeek WH, Al-Toma A, Schreurs MW, Kuik DJ, Visser OJ et al. Effectiveness of cladribine therapy in refractory coeliac disease type II. Gut 2009; 58 (Suppl II): A72 . Ref type: Abstract.
Verbeek WH, Van De Water JM, Al-Toma A, Oudejans JJ, Mulder CJ, Coupe VM . Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in the Netherlands. Scand J Gastroenterol 2008; 43: 1322–1328.
Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P et al. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br J Haematol 1999; 105: 775–779.
DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 2009; 113: 5720–5726.
Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, Schreurs MW . Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom 2009; 76: 367–374.
Acknowledgements
This study was supported by an unrestricted grant from AstraZeneca. There was no affiliation potentially able to introduce a bias.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Tack, G., Wondergem, M., Al-Toma, A. et al. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant 46, 840–846 (2011). https://doi.org/10.1038/bmt.2010.199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.199
Keywords
This article is cited by
-
Refractory Celiac Disease
Current Gastroenterology Reports (2020)
-
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Bone Marrow Transplantation (2020)
-
Mechanisms and management of refractory coeliac disease
Nature Reviews Gastroenterology & Hepatology (2015)
-
Are stem cells a potential therapeutic tool in coeliac disease?
Cellular and Molecular Life Sciences (2015)